432 related articles for article (PubMed ID: 31672794)
1. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
Seethapathy H; Zhao S; Chute DF; Zubiri L; Oppong Y; Strohbehn I; Cortazar FB; Leaf DE; Mooradian MJ; Villani AC; Sullivan RJ; Reynolds K; Sise ME
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1692-1700. PubMed ID: 31672794
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
Cortazar FB; Kibbelaar ZA; Glezerman IG; Abudayyeh A; Mamlouk O; Motwani SS; Murakami N; Herrmann SM; Manohar S; Shirali AC; Kitchlu A; Shirazian S; Assal A; Vijayan A; Renaghan AD; Ortiz-Melo DI; Rangarajan S; Malik AB; Hogan JJ; Dinh AR; Shin DS; Marrone KA; Mithani Z; Johnson DB; Hosseini A; Uprety D; Sharma S; Gupta S; Reynolds KL; Sise ME; Leaf DE
J Am Soc Nephrol; 2020 Feb; 31(2):435-446. PubMed ID: 31896554
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Koks MS; Ocak G; Suelmann BBM; Hulsbergen-Veelken CAR; Haitjema S; Vianen ME; Verhaar MC; Kaasjager KAH; Khairoun M
PLoS One; 2021; 16(6):e0252978. PubMed ID: 34101756
[TBL] [Abstract][Full Text] [Related]
5. Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes.
Meraz-Muñoz A; Amir E; Ng P; Avila-Casado C; Ragobar C; Chan C; Kim J; Wald R; Kitchlu A
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32601079
[TBL] [Abstract][Full Text] [Related]
6. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus.
Thakar CV; Christianson A; Himmelfarb J; Leonard AC
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2567-72. PubMed ID: 21903988
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.
Heung M; Steffick DE; Zivin K; Gillespie BW; Banerjee T; Hsu CY; Powe NR; Pavkov ME; Williams DE; Saran R; Shahinian VB;
Am J Kidney Dis; 2016 May; 67(5):742-52. PubMed ID: 26690912
[TBL] [Abstract][Full Text] [Related]
8. Cohort study on immune checkpoint inhibitor-associated acute kidney injury: Incidence, risk factors, and management strategies.
Panich J; Irwin C; Bissonette A; Elkhidir S; Lodhi F; Folz C; Lee J; Pulipati S; Fatima Z; Gopinath P; Blonsky R; Abboud Leon C; Kattamanchi S
J Oncol Pharm Pract; 2024 Mar; 30(2):286-294. PubMed ID: 37125423
[TBL] [Abstract][Full Text] [Related]
9. Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors.
Seethapathy H; Zhao S; Strohbehn IA; Lee M; Chute DF; Bates H; Molina GE; Zubiri L; Gupta S; Motwani S; Leaf DE; Sullivan RJ; Rahma O; Blumenthal KG; Villani AC; Reynolds KL; Sise ME
Kidney Int Rep; 2020 Oct; 5(10):1700-1705. PubMed ID: 33102962
[TBL] [Abstract][Full Text] [Related]
10. Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.
Espi M; Teuma C; Novel-Catin E; Maillet D; Souquet PJ; Dalle S; Koppe L; Fouque D
Eur J Cancer; 2021 Apr; 147():29-39. PubMed ID: 33607383
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with immune check point inhibitors and acute kidney injury.
Valentin A; Møller AKH; Palshof JA; Broberg B; Gravesen E; Svane IM; Hansen D
Acta Oncol; 2023 Feb; 62(2):121-125. PubMed ID: 36755491
[TBL] [Abstract][Full Text] [Related]
12. The association between proton pump inhibitor use and risk of post-hospitalization acute kidney injury: a multicenter prospective matched cohort study.
Zhang Y; Ghahramani N; Razjouyan H; Ba DM; Chinchilli VM
BMC Nephrol; 2023 May; 24(1):150. PubMed ID: 37237361
[TBL] [Abstract][Full Text] [Related]
13. Processes of Care After Hospital Discharge for Survivors of Acute Kidney Injury: A Population-Based Cohort Study.
Brar S; Ye F; James MT; Harrison TG; Pannu N;
Am J Kidney Dis; 2024 Feb; 83(2):216-228. PubMed ID: 37734688
[TBL] [Abstract][Full Text] [Related]
14. Acute Kidney Injury in Subjects With Chronic Kidney Disease Undergoing Total Joint Arthroplasty.
Soliman KM; Campbell RC; Fülöp T; Goddard T; Pisoni R
Am J Med Sci; 2019 Jul; 358(1):45-50. PubMed ID: 31079840
[TBL] [Abstract][Full Text] [Related]
15. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
[TBL] [Abstract][Full Text] [Related]
16. Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors.
Seethapathy H; Street S; Strohbehn I; Lee M; Zhao SH; Rusibamayila N; Chute DF; Gao X; Michaelson MD; Rahma OE; Choueiri TK; McGregor B; Sonpavde G; Salabao C; Kaymakcalan MD; Wei X; Gupta S; Motwani S; Leaf DE; Reynolds KL; Sise ME
Eur J Cancer; 2021 Nov; 157():50-58. PubMed ID: 34482189
[TBL] [Abstract][Full Text] [Related]
17. Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis.
Abdelrahim M; Mamlouk O; Lin H; Lin J; Page V; Abdel-Wahab N; Swan J; Selamet U; Yee C; Diab A; Suki W; Abudayyeh A
Oncoimmunology; 2021 May; 10(1):1927313. PubMed ID: 34104543
[No Abstract] [Full Text] [Related]
18. Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19.
Nugent J; Aklilu A; Yamamoto Y; Simonov M; Li F; Biswas A; Ghazi L; Greenberg H; Mansour G; Moledina G; Wilson FP
JAMA Netw Open; 2021 Mar; 4(3):e211095. PubMed ID: 33688965
[TBL] [Abstract][Full Text] [Related]
19. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.
Manohar S; Ghamrawi R; Chengappa M; Goksu BNB; Kottschade L; Finnes H; Dronca R; Leventakos K; Herrmann J; Herrmann SM
Kidney360; 2020 Jan; 1(1):16-24. PubMed ID: 35372854
[TBL] [Abstract][Full Text] [Related]
20. Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors.
García-Carro C; Bolufer M; Bury R; Castañeda Z; Muñoz E; Felip E; Lorente D; Carreras MJ; Gabaldon A; Agraz I; Serón D; Soler MJ
Nephrol Dial Transplant; 2022 Apr; 37(5):887-894. PubMed ID: 33547795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
